Brenner tumor of ovary
Please note that the links contained on this search results page may take you
to sites outside of the NIH. (See Disclaimer under Site Policies for details.)
Brenner tumors, first described in 1898, are small, unilateral, firm, smooth and solid fibroepithelial ovarian tumors that are generally asymptomatic.[1][2][3] The current preferred term for benign Brenner tumors is transitional cell tumors.[2] The benign, proliferative (low malignant potential), and malignant forms together comprise approximately 2% of ovarian tumors.[1][2] These tumors usually occur in women ages 40 to 60 years.[2] Management is operative.[2][3] When confined to the ovary, these tumors carry a good-to-excellent prognosis, depending on the malignancy status.[1]
For more information about Brenner tumor of ovary click on the boxes below:
|
|
More Detailed Information (Found 2 resources)
Links where you can find more general information, comprehensive resources, selected full text journal articles, and news updates
-
General
-
eMedicine provides information on this topic. Click on the link to view this information. You may need to register to view the medical textbook, but registration is free
-
PubMed is a searchable database of medical literature and lists journal articles that discuss Brenner tumor of ovary. Click on the link to view a sample search on this topic.
|
|
|
NLM Gateway (Found 1 resource)
A tool to search across multiple resources offered on the National Library of Medicine's Website
-
-
NLM Gateway allows users to search many resources offered on the National Library of Medicine's Web site at once to quickly find more information about this condition. Some of the resources may be a duplicate of the resources listed on this page. To search NLM Gateway, click on the link; the condition name will already be in the search box, so you can just click the “Search” button.
|
|
Umbrella Organizations | Disease-Specific Organizations | Live Chat/E-mail Lists | Parent Matching Organizations
|
Support Groups (Found 7 resources)
Groups providing a wide range of services, supportive resources, and information
-
Umbrella Organizations
-
Genetic Alliance
4301 Connecticut Avenue NW Suite 404 Washington, DC 20008-2369 Telephone: 202-966-5557 Fax: 202-966-8553 E-mail: info@geneticalliance.org Web site: http://www.geneticalliance.org
-
National Organization for Rare Disorders (NORD)
55 Kenosia Avenue PO Box 1968 Danbury, CT 06813-1968 Toll-free: 1-800-999-6673 (voicemail only) Telephone: 203-744-0100 TTY: 203-797-9590 Fax: 203-798-2291 E-mail: orphan@rarediseases.org Web site: http://www.rarediseases.org/
-
Disease-Specific Organizations
-
National Ovarian Cancer Coalition
2501 Oak Lawn Avenue, Suite 435 Dallas, TX 75219 Toll-free: 888-OVARIAN Telephone: 214-273-4200 Fax: 214-273-4201 E-mail: nocc@ovarian.org Web site: http://www.ovarian.org/
-
Ovarian Cancer National Alliance
910 17th Street, N.W., Suite 1190 Washington, D.C. 20006 Toll-free: 866-399-6262 Telephone: 202-331-1332 Fax: 202-331-2292 E-mail: ocna@ovariancancer.org Web site: http://www.ovariancancer.org/
-
Live Chat/E-mail Lists
-
The National Organization of Rare Disorders (NORD) has partnered with Inspire.com to launch an online community for people with rare diseases called The NORD Rare Disease Community. This community connects medical patients, family members, caregivers, and professionals. Click on The NORD Rare Disease Community to learn more.
-
RareShare is an online social hub dedicated to patients, families and healthcare professionals affected by rare medical disorders. Click on RareShare to learn more.
-
Parent Matching Organizations
-
Madisons Foundation
P.O. Box 241956 Los Angeles, CA 90024 Telephone: 310-264-0826 Fax: 310-264-4766 E-mail: getinfo@madisonsfoundation.org Web site: http://www.madisonsfoundation.org/
|
|
|
Clinical Trials & Research (Found 1 resource)
Resources where you may find research studies and clinical trials
-
-
ClinicalTrials.gov lists trials that are studying or have studied Brenner tumor of ovary. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.
|